Watchlist Price Alert

BioCryst Pharmaceuticals ... (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

10.05

-0.24 (-2.33%)

At close: Jun 17, 2025, 10:52 AM

BioCryst Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	104.71M	110.64M	304.77M	504.39M	272.13M	114.17M	26.73M	50.28M	22.1M
Short-Term Investments	216.14M	278.34M	119.54M	3.21M	28.24M	22.05M	77.74M	64.11M	32.55M
Long-Term Investments	20.32M	n/a	18.08M	6.83M	n/a	n/a	22.38M	41.3M	8.93M
Other Long-Term Assets	28.34M	80K	6.81M	n/a	3.8M	3.59M	978K	2.03M	4.01M
Receivables	79.07M	56.95M	50.6M	29.41M	8.65M	22.15M	4.29M	6.12M	8.77M
Inventory	8.09M	28.68M	27.53M	15.79M	7.04M	1.55M	1.65M	-37.8M	500K
Other Current Assets	13.96M	1.8M	1.47M	3.35M	2.22M	1.55M	1.54M	3.5M	1.63M
Total Current Assets	421.97M	495.97M	516.5M	566.14M	323.8M	164.34M	114.35M	125.39M	66.99M
Property-Plant & Equipment	19.79M	20.91M	15.42M	15.19M	7.11M	7.35M	9.13M	9.55M	9.92M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	68.45M	20.99M	33.5M	22.02M	10.91M	10.94M	32.49M	52.87M	22.86M
Total Assets	490.42M	516.96M	550M	588.15M	334.71M	175.28M	146.84M	178.26M	89.85M
Account Payables	11.64M	20.89M	14.36M	27.81M	18.71M	13.99M	7.77M	6.34M	4.27M
Deferred Revenue	n/a	n/a	1.22M	1.42M	150K	2.12M	221K	8.48M	2.02M
Short-Term Debt	35.45M	23.57M	n/a	n/a	30M	38.58M	33.7M	35.15M	28.24M
Other Current Liabilities	64.66M	66.36M	65.44M	52M	44.58M	30.08M	23.08M	21.89M	19.4M
Total Current Liabilities	160.38M	149.99M	105.51M	103.72M	105.65M	92.33M	69.48M	74.84M	54.36M
Long-Term Debt	795.92M	811.26M	733.28M	585.46M	244.45M	41.29M	25.37M	16.75M	22.78M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	54K	155K	244K
Total Long-Term Liabilities	805.97M	822.5M	739.08M	591.42M	248.32M	44.7M	28.13M	19.66M	33.91M
Total Liabilities	966.35M	972.49M	844.6M	695.14M	353.98M	137.03M	97.61M	94.49M	88.27M
Total Debt	808.74M	848.71M	741.45M	593.24M	279.5M	84.65M	61.82M	54.72M	53.72M
Common Stock	2.08M	2.06M	1.88M	1.84M	1.77M	1.54M	1.1M	984K	738K
Retained Earnings	-1.77B	-1.68B	-1.45B	-1.21B	-1.02B	-840.63M	-731.97M	-631.84M	-566.06M
Comprehensive Income	921K	1.34M	26K	177K	3K	39K	-297K	-243K	-12K
Shareholders Equity	-475.93M	-455.53M	-294.6M	-106.99M	-19.26M	-840.63M	-731.97M	-631.84M	-566.06M
Total Investments	236.46M	278.34M	137.62M	10.04M	28.24M	22.05M	100.11M	105.41M	41.47M